AGT and type 2 diabetes mellitus: A recent report showed that serum bilirubin levels were inversely associated with progression of nephropathy in a post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial12.